{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CPRX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T15:59:53.050Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":652,"canonical_name":"CATALYST PHARMACEUTICALS, INC.","cik":"0001369568","uei":null,"lei":null,"duns":null,"ticker":"CPRX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":58},"count":58,"timeline":[{"ts":"2026-07-24","kind":"sec.filing","form_type":"15-12G","title":"15-12G — CATALYST PHARMACEUTICALS, INC. — 2026-07-24","url_slug":"/sec/cik-0001369568/15-12g/0001193125-26-315836","accession_number":"0001193125-26-315836","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — CATALYST PHARMACEUTICALS, INC. — 2026-07-17","url_slug":"/sec/cik-0001369568/4/0001161697-26-000171","accession_number":"0001161697-26-000171","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — CATALYST PHARMACEUTICALS, INC. — 2026-07-17","url_slug":"/sec/cik-0001369568/4/0001161697-26-000172","accession_number":"0001161697-26-000172","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — CATALYST PHARMACEUTICALS, INC. — 2026-07-17","url_slug":"/sec/cik-0001369568/4/0001161697-26-000173","accession_number":"0001161697-26-000173","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — CATALYST PHARMACEUTICALS, INC. — 2026-07-17","url_slug":"/sec/cik-0001369568/4/0001161697-26-000174","accession_number":"0001161697-26-000174","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — CATALYST PHARMACEUTICALS, INC. — 2026-07-17","url_slug":"/sec/cik-0001369568/4/0001161697-26-000176","accession_number":"0001161697-26-000176","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — CATALYST PHARMACEUTICALS, INC. — 2026-07-17","url_slug":"/sec/cik-0001369568/4/0001161697-26-000177","accession_number":"0001161697-26-000177","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — CATALYST PHARMACEUTICALS, INC. — 2026-07-17","url_slug":"/sec/cik-0001369568/4/0001161697-26-000178","accession_number":"0001161697-26-000178","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — CATALYST PHARMACEUTICALS, INC. — 2026-07-17","url_slug":"/sec/cik-0001369568/4/0001161697-26-000179","accession_number":"0001161697-26-000179","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — CATALYST PHARMACEUTICALS, INC. — 2026-07-17","url_slug":"/sec/cik-0001369568/4/0001161697-26-000180","accession_number":"0001161697-26-000180","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — CATALYST PHARMACEUTICALS, INC. — 2026-07-17","url_slug":"/sec/cik-0001369568/4/0001161697-26-000181","accession_number":"0001161697-26-000181","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — CATALYST PHARMACEUTICALS, INC. — 2026-07-17","url_slug":"/sec/cik-0001369568/4/0001161697-26-000182","accession_number":"0001161697-26-000182","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — CATALYST PHARMACEUTICALS, INC. — 2026-07-17","url_slug":"/sec/cik-0001369568/4/0001161697-26-000183","accession_number":"0001161697-26-000183","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"8-K","title":"8-K — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/8-k/0001193125-26-304984","accession_number":"0001193125-26-304984","importance":35},{"ts":"2026-07-16","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/effect/9999999995-26-002324","accession_number":"9999999995-26-002324","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/effect/9999999995-26-002325","accession_number":"9999999995-26-002325","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/effect/9999999995-26-002321","accession_number":"9999999995-26-002321","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/effect/9999999995-26-002322","accession_number":"9999999995-26-002322","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/effect/9999999995-26-002323","accession_number":"9999999995-26-002323","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"POS AM","title":"POS AM — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/pos-am/0001193125-26-305088","accession_number":"0001193125-26-305088","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"POS AM","title":"POS AM — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/pos-am/0001193125-26-305097","accession_number":"0001193125-26-305097","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"POS AM","title":"POS AM — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/pos-am/0001193125-26-305098","accession_number":"0001193125-26-305098","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"POS AM","title":"POS AM — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/pos-am/0001193125-26-305099","accession_number":"0001193125-26-305099","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"POS AM","title":"POS AM — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/pos-am/0001193125-26-305103","accession_number":"0001193125-26-305103","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"POSASR","title":"POSASR — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/posasr/0001193125-26-305106","accession_number":"0001193125-26-305106","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/s-8-pos/0001193125-26-305107","accession_number":"0001193125-26-305107","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/s-8-pos/0001193125-26-305110","accession_number":"0001193125-26-305110","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/s-8-pos/0001193125-26-305113","accession_number":"0001193125-26-305113","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/s-8-pos/0001193125-26-305114","accession_number":"0001193125-26-305114","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/s-8-pos/0001193125-26-305115","accession_number":"0001193125-26-305115","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/s-8-pos/0001193125-26-305117","accession_number":"0001193125-26-305117","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/s-8-pos/0001193125-26-305120","accession_number":"0001193125-26-305120","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — CATALYST PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001369568/s-8-pos/0001193125-26-305126","accession_number":"0001193125-26-305126","importance":30},{"ts":"2026-07-15","kind":"sec.insider.d","reporter":"MCENANY PATRICK J","title":"","shares":4171559,"price_per_share":31.5,"usd_value":131404109,"security_title":"Common Stock, par value $0.001 per share","importance":55},{"ts":"2026-07-15","kind":"sec.insider.d","reporter":"Miller Steve","title":"Chief Op. & Scientific Officer","shares":1093803,"price_per_share":31.5,"usd_value":34454795,"security_title":"Common Stock, par value $0.001 per share","importance":49.4547945},{"ts":"2026-07-15","kind":"sec.insider.d","reporter":"DENKHAUS DONALD A","title":"","shares":498773,"price_per_share":31.5,"usd_value":15711350,"security_title":"Common Stock, par value $0.001 per share","importance":30.7113495},{"ts":"2026-07-15","kind":"sec.insider.d","reporter":"Tierney David S","title":"","shares":383314,"price_per_share":31.5,"usd_value":12074391,"security_title":"Common Stock, par value $0.001 per share","importance":27.074391},{"ts":"2026-07-15","kind":"sec.insider.d","reporter":"Daly Richard J","title":"President and CEO","shares":271266,"price_per_share":31.5,"usd_value":8544879,"security_title":"Common Stock, par value $0.001 per share","importance":23.544879},{"ts":"2026-07-15","kind":"sec.insider.d","reporter":"Elsbernd Brian","title":"Chief Legal Officer","shares":242501,"price_per_share":31.5,"usd_value":7638782,"security_title":"Common Stock, par value $0.001 per share","importance":22.6387815},{"ts":"2026-07-15","kind":"sec.insider.d","reporter":"Sundaram Preethi","title":"Chief Strategy Officer","shares":54804,"price_per_share":31.5,"usd_value":1726326,"security_title":"Common Stock, par value $0.001 per share","importance":16.726326},{"ts":"2026-07-15","kind":"sec.insider.d","reporter":"Del Carmen Jeffrey","title":"Chief Commercial Officer","shares":14337,"price_per_share":31.5,"usd_value":451616,"security_title":"Common Stock, par value $0.001 per share","importance":15.4516155},{"ts":"2026-07-15","kind":"sec.insider.d","reporter":"Kalb Michael Wayne","title":"Chief Financial Officer","shares":13665,"price_per_share":31.5,"usd_value":430448,"security_title":"Common Stock, par value $0.001 per share","importance":15.4304475},{"ts":"2026-07-15","kind":"sec.insider.d","reporter":"Thompson Tamar","title":"","shares":3773,"price_per_share":31.5,"usd_value":118850,"security_title":"Common Stock, par value $0.001 per share","importance":15.1188495},{"ts":"2026-07-15","kind":"sec.insider.d","reporter":"Harper Molly","title":"","shares":3694,"price_per_share":31.5,"usd_value":116361,"security_title":"Common Stock, par value $0.001 per share","importance":15.116361},{"ts":"2026-07-15","kind":"sec.insider.d","reporter":"Andrews William T.","title":"Chief Medical Officer","shares":2309,"price_per_share":31.5,"usd_value":72734,"security_title":"Common Stock, par value $0.001 per share","importance":15.0727335},{"ts":"2026-07-15","kind":"sec.insider.d","reporter":"Russo Gregg","title":"Chief HR Officer","shares":476,"price_per_share":31.5,"usd_value":14994,"security_title":"Common Stock, par value $0.001 per share","importance":15.014994},{"ts":"2026-07-08","kind":"sec.filing","form_type":"8-K","title":"8-K — CATALYST PHARMACEUTICALS, INC. — 2026-07-08","url_slug":"/sec/cik-0001369568/8-k/0001193125-26-298739","accession_number":"0001193125-26-298739","importance":35},{"ts":"2026-06-30","kind":"sec.filing","form_type":"8-K","title":"8-K — CATALYST PHARMACEUTICALS, INC. — 2026-06-30","url_slug":"/sec/cik-0001369568/8-k/0001193125-26-290768","accession_number":"0001193125-26-290768","importance":35},{"ts":"2026-06-30","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — CATALYST PHARMACEUTICALS, INC. — 2026-06-30","url_slug":"/sec/cik-0001369568/defa14a/0001193125-26-290840","accession_number":"0001193125-26-290840","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"8-K","title":"8-K — CATALYST PHARMACEUTICALS, INC. — 2026-06-23","url_slug":"/sec/cik-0001369568/8-k/0001193125-26-279776","accession_number":"0001193125-26-279776","importance":35},{"ts":"2026-06-08","kind":"sec.filing","form_type":"DEFM14A","title":"DEFM14A — CATALYST PHARMACEUTICALS, INC. — 2026-06-08","url_slug":"/sec/cik-0001369568/defm14a/0001193125-26-261719","accession_number":"0001193125-26-261719","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — CATALYST PHARMACEUTICALS, INC. — 2026-06-05","url_slug":"/sec/cik-0001369568/4/0001161697-26-000132","accession_number":"0001161697-26-000132","importance":30},{"ts":"2026-06-03","kind":"sec.insider.m","reporter":"Andrews William T.","title":"Chief Medical Officer","shares":3052,"price_per_share":null,"usd_value":0,"security_title":"Common Stock, par value $0.001 per share","importance":15},{"ts":"2026-06-03","kind":"sec.insider.f","reporter":"Andrews William T.","title":"Chief Medical Officer","shares":743,"price_per_share":null,"usd_value":0,"security_title":"Common Stock, par value $0.001 per share","importance":15},{"ts":"2026-05-12","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — CATALYST PHARMACEUTICALS, INC. — 2026-05-12","url_slug":"/sec/cik-0001369568/defa14a/0001193125-26-218309","accession_number":"0001193125-26-218309","importance":30},{"ts":"2026-05-11","kind":"sec.filing","form_type":"10-Q","title":"10-Q — CATALYST PHARMACEUTICALS, INC. — 2026-05-11","url_slug":"/sec/cik-0001369568/10-q/0001369568-26-000002","accession_number":"0001369568-26-000002","importance":45},{"ts":"2026-05-11","kind":"sec.filing","form_type":"8-K","title":"8-K — CATALYST PHARMACEUTICALS, INC. — 2026-05-11","url_slug":"/sec/cik-0001369568/8-k/0001193125-26-216929","accession_number":"0001193125-26-216929","importance":35},{"ts":"2026-05-08","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — CATALYST PHARMACEUTICALS, INC. — 2026-05-08","url_slug":"/sec/cik-0001369568/defa14a/0001193125-26-215061","accession_number":"0001193125-26-215061","importance":30}]}